DRUGMAKER TAKEDA BUYS SHIRE FOR $64 BILLION

Japanese drugmaker Takeda agreed to buy Ireland-based Shire for $64 billion. Shire focuses on rare diseases and has large operations in the U.S., where it gets more than two-thirds of its revenue. Takeda makes almost half of its sales in Asia and about a third in the U.S.